Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics - Wikidata - wikimedia - TriplyDB

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

http://www.wikidata.org/entity/Q28751743

about

sameAs

Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß Suppression of breast tumor growth and metastasis by an engineered transcription factor Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells PI3K/Akt/mTOR inhibitors in breast cancer Understanding the role of the kynurenine pathway in human breast cancer immunobiology Claudin 1 in Breast Cancer: New Insights The fate of chemoresistance in triple negative breast cancer (TNBC)Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management Triple negative breast cancer: looking for the missing link between biology and treatments Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer Emerging role of cell polarity proteins in breast cancer progression and metastasis The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling Ovarian cancer biomarker discovery based on genomic approaches Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.Endothelial protein C receptor function in murine and human breast cancer development Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer Mechanisms involved in breast cancer liver metastasis Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer DLG5 in cell polarity maintenance and cancer development Order and disorder in large multi-site docking proteins of the Gab family--implications for signalling complex formation and inhibitor design strategies Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy Reverse phase protein microarrays advance to use in clinical trials The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis Reinventing diagnostics for personalized therapy in oncology The Regulatory Role of MicroRNAs in EMT and Cancer Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4 Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

P2860

Q21133567-E0A37CA8-3135-4D40-BAA8-0365A8DF9CEB Q21135222-F6532684-891C-4387-A446-5710D8DB2CC5 Q24633875-50D76A36-B159-492E-B2DF-FD56709D197F Q26743510-BDF5F188-CB38-46CE-9375-408696D71A83 Q26748850-E1E07A74-E101-4AAB-94FE-2ECC81CBBCF5 Q26771394-CE933499-FB81-44D5-9D5B-356745435485 Q26773472-9A6E5FC2-B96A-4F90-B9B5-AB7EC5FB6265 Q26774988-70ADE82B-F13B-43CA-9A20-A556A3A7C415 Q26775232-784AA412-1109-4EE8-AC11-F675C634D278 Q26782664-94978714-28B0-4885-A49C-9B155E0A8173 Q26783122-B1AC180F-C605-4E97-9EF0-6A860AB681C6 Q26829478-4BA1F7AC-8576-42E5-879B-39D3EDDBD571 Q26851833-CF5EDD3E-39B2-40D6-8A74-F4A8A49BB461 Q26865458-C0F369CF-6BDC-4272-B1EF-03D07ED50BCC Q26866067-B3EC7AFA-847F-4FDA-9C54-DC5D3DB48053 Q27011423-CDAB52CB-E610-4EF6-9BE3-F29B816EAE73 Q27013687-314C0896-4A48-4E96-B932-EEAFD65A6A2A Q27311085-2E15FAAF-4374-4BA6-8EE3-CC172D2FA5C8 Q27327182-9BC41AF0-C94C-47A6-8BF6-3B487E19AC62 Q28082679-25237157-767E-4C31-8BBF-8E834C691E5D Q28084024-D77A1DF3-532A-4648-B201-10506718C987 Q28087050-E5A52CFF-944F-4DCC-AF57-5F3FB4B1806B Q28115315-78DB59FB-49B9-41FF-BF68-B535153BAD08 Q28241647-F46AF7EF-A2CC-4886-8CB2-4D5EB72BF4DE Q28248627-D88D8DD1-6E92-4690-99F0-01A68281074F Q28269714-7796C5C4-78C8-4C4E-9A7C-04B072AD4217 Q28276295-0990BCF6-8168-4C72-B1D2-1E0A3D9A7612 Q28384553-6F29A5B3-4B61-4770-805B-4B4B68EDA77C Q28388257-38A15302-01F4-4083-9F6F-610E475BBE99 Q28391395-26BFAD2B-122D-4DBC-A288-D52C1612CB97 Q28391426-D2E67C87-A306-4C41-811D-97C8E6F97E9C Q28484040-CA6DBEBA-A2C5-4994-988A-999802200456 Q28534173-EE0EA32A-D2CD-43A6-A383-096D2E81E49D Q28730141-6F3C3756-E2BA-4722-9CF4-652A4B983CFF Q29617680-2C67AE70-CB7D-49B5-AED0-842ECC0B3DC3 Q29619481-E9FAC87A-DBA3-4637-A97A-4D57B19891A4 Q29620020-56005C0B-14E1-45F9-A5F0-D3BAFD0D3174 Q30245184-2679D427-84F0-4D38-B743-EB134E95CF13 Q30447049-E6728451-487A-423F-8FCA-332C095F9226 Q30496002-8A7FFD11-002B-46F1-8326-33B9770A2083

P2860

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

http://www.wikidata.org/entity/Q28751743

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Characterization of a naturall ...... and stem cell characteristics

@ast

Characterization of a naturall ...... and stem cell characteristics

@en

Characterization of a naturall ...... and stem cell characteristics

@nl

type

label

Characterization of a naturall ...... and stem cell characteristics

@ast

Characterization of a naturall ...... and stem cell characteristics

@en

Characterization of a naturall ...... and stem cell characteristics

@nl

prefLabel

Characterization of a naturall ...... and stem cell characteristics

@ast

Characterization of a naturall ...... and stem cell characteristics

@en

Characterization of a naturall ...... and stem cell characteristics

@nl

P1433

Q28751743-589F5551-3883-4B53-B154-0594132F740A

P1476

Q28751743-D2390CCD-D950-4881-A22A-27858A6435A1

P2093

Q28751743-0F38E0D6-B335-420B-9283-76016CBE4B36

Q28751743-1A9452FC-64E3-4C3E-B3DC-97E6EEDD4272

Q28751743-1C575369-CF93-47B8-9813-49B3E8E882F0

Q28751743-28DF3039-F26A-4509-B16C-76F60A625FE6

Q28751743-2E5C23D9-B1A4-43FC-AF54-B1F2BF72289A

Q28751743-3FC0B69A-CF25-490D-B96E-96B9973B584E

Q28751743-45A75F25-583B-4A27-9D61-825229161DF2

Q28751743-463214E3-2325-4DE6-BEDD-4D10C5D0B537

Q28751743-46D3160D-0A00-4B7D-90B2-53100B64502F

Q28751743-496F9C2E-57ED-49C6-BC59-D5D6A9F305FE

P2860

Q28751743-01C44540-954C-4039-8523-BF7BFC41E0F6

Q28751743-01C50695-32A7-4A10-B287-9A474F7BBAAC

Q28751743-03897278-693B-4708-B673-E55B3BD4C16D

Q28751743-049883D3-81EB-4B95-97E1-C8E5318607AA

Q28751743-080B6E0E-D4F7-41D0-8C94-43D36458AF8A

Q28751743-0A9A7E52-B0DF-4086-9ED5-A417B85CCA58

Q28751743-12CF850B-3844-401B-B607-B4B18AE016BF

Q28751743-14B85C8A-6F8C-4AF8-9B87-E21F7D431EDF

Q28751743-26CFA014-61C9-4CAE-827F-B5CCEDAF6562

Q28751743-27311B23-2EA7-4C9B-924C-8A4644F5A304

P304

Q28751743-E3E3E777-4A0E-44CA-BA6F-78530D911E13

P31

Q28751743-2DC765CE-8BD1-4123-8260-A4B2490A716E

P3181

Q28751743-7FDAA8AA-D24E-45A9-A1E0-4CE3E20BC858

P356

Q28751743-9108A629-180D-496D-9BC4-1FA9BF972C90

P407

Q28751743-0973E3EC-299A-425F-8A49-FD083BF97A4F

P433

Q28751743-FE33C4EF-F3CD-41B7-BE20-0FE0B5F1698A

P478

Q28751743-2539D009-2E09-42D0-AF77-40CE372F4FBC

P50

Q28751743-EC02A81F-66EF-4A85-A97F-BB4D45F6705D

P577

Q28751743-C0547444-76E5-4B45-8E6E-2A7E7E9B470F

P698

Q28751743-F4A695FF-8835-436F-B5B7-24C6AAEA5AAA

P932

Q28751743-3E882448-6790-4C55-A0F9-79C0FF7ED285

P3181

P356

0008-5472.CAN-08-3441

P1433

Cancer Research

P1476

Characterization of a naturall ...... and stem cell characteristics

@en

P2093

Ana Lluch

http://www.w3.org/2001/XMLSchema#string

Ana-Maria Gonzalez-Angulo

http://www.w3.org/2001/XMLSchema#string

Aysegul Sahin

http://www.w3.org/2001/XMLSchema#string

Bryan T Hennessy

http://www.w3.org/2001/XMLSchema#string

Carlos Monteagudo

http://www.w3.org/2001/XMLSchema#string

Cheng Fan

http://www.w3.org/2001/XMLSchema#string

Corwin Joy

http://www.w3.org/2001/XMLSchema#string

David Stivers

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

P2860

Significance analysis of microarrays applied to the ionizing radiation response

The epithelial-mesenchymal transition generates cells with properties of stem cells

Gamma-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans

Determination of stromal signatures in breast carcinoma.

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

Molecular definition of breast tumor heterogeneity

P304

4116-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

548712

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-08-3441

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

P577

2009-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19435916

http://www.w3.org/2001/XMLSchema#string

P932

2737191

http://www.w3.org/2001/XMLSchema#string